News & analysis
Daily outsourcing headlines and weekly deep dives for CRO and CDMO teams — published on the canonical directory for each site.
Feed: /api/seo/feed · Markdown mirrors: /posts/<slug>.md
- CDMO Daily News — June 24, 2026
Last updated: 2026-06-24T00:00:30.113Z
EMA Convenes AI in GMP Workshop to Shape Annex 22 Guidance on Adaptive Models EMA hosts twoday multistakeholder workshop (30 June–1 July 2026) to gather expert input on responsible AI use in medicine…
- 503B Outsourcing Facilities & FDA Drug Shortages: Can CDMOs Close the Supply Gap?
Last updated: 2026-06-18T05:00:37.940Z
Modern Catalyst The U.S. drug shortage crisis has reached a structural inflection point. As of 2025, the FDA's shortage inventory reflects persistent gaps in critical injectable medications, oncology…
- CDMO Daily News — June 15, 2026
Last updated: 2026-06-15T23:59:41.939Z
CCRM's OmniaBio Partners with [Avectas](/companies/avectas) to Advance Automated Cell Therapy Manufacturing OmniaBio, Canada's largest cell and gene therapy CDMO, will evaluate [Avectas](/companies/a…
- CDMO Daily News — June 11, 2026
Last updated: 2026-06-11T05:46:54.699Z
Scinai Completes Recipharm Israel Acquisition, Expands CDMO Platform to Two Sites Scinai acquired Recipharm Israel's Yavne facility, adding a second manufacturing site and $3.6 million in equipment t…
- Sterile Biologics Capacity Crunch: How to Secure CDMO Slots in 2026
Last updated: 2026-06-11T05:23:06.521Z
Modern Catalyst The biologics revolution is colliding with manufacturing reality. As monoclonal antibodies, cell and gene therapies, and biosimilars flood development pipelines, contract development…
- CDMO Daily News — June 9, 2026
Last updated: 2026-06-09T05:17:09.193Z
Cell & Gene Therapy CDMOs Address Manufacturing Complexity and Capacity Gaps — CGT market projected to reach $143.6 billion by 2034 (31% CAGR), driving demand for specialized manufacturing and supply…
- CDMO Daily News — June 6, 2026
Last updated: 2026-06-06T20:56:20.513Z
Grifols Supports AlphaDetect to Accelerate Detection of Alpha1 — The sponsorship will help expand proven strategies to consistently detect a genetic, irreversible, and progressive condition in patien…